Intuitive Surgical downgraded to Hold from Buy at Cantor Cantor Fitzgerald downgraded Intuitive Surgical citing valuation with the stock up 18% year-to-date. Cantor says the Veteran's Administration procurement is an incremental positive, but it prefers to move to the sidelines pending greater clarity on Intuitive's reacceleration of revenue growth in 2015. The firm keeps a $450 price target for shares, which closed yesterday up $9.01 to $453.84.
Intuitive Surgical initiated with a Neutral at Piper Jaffray Piper Jaffray analyst Matt O'Brien started shares of Intuitive Surgical with a Neutral rating and $505 price target. O'Brien calls the stock "simply too expensive" relative to expected sales and earnings, but admits Intuitive's robotic surgical technology will likely dominate the market in the coming years. Further, the analyst thinks the company's da Vinci Prostatectomy and da Vinci Hysterectomy procedures could contract amid new diagnostic tests and insurance pushback. The stock closed yesterday up $2.05 to $496.37.